Skip to main content
Vigonvita Life Sciences Co., Ltd. logo

Vigonvita Life Sciences Co., Ltd. — Investor Relations & Filings

Ticker · 2630 ISIN · CNE1000076N3 HKEX Manufacturing
Open in API
Filings indexed 45 across all filing types
Latest filing 2025-11-27 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2630

About Vigonvita Life Sciences Co., Ltd.

http://www.vigonvita.cn

Vigonvita Life Sciences Co., Ltd. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative small-molecule drugs. The company operates an integrated R&D platform targeting high-need therapeutic areas, specifically neurological and neuropsychiatric disorders, reproductive health, and viral infections. Its comprehensive pipeline includes the oral nucleoside antiviral candidate MINDVY® (VV116), which has been clinically studied for COVID-19 and RSV, and ONVITA® (TPN171). Vigonvita emphasizes high-quality development, evidenced by its participation in significant national programs, including the National Key R&D Program and the Major New Drug Innovation Technology Major Project, often involving international clinical research collaborations.

Recent filings

Filing Released Lang Actions
INSIDE INFORMATION - PROPOSED IMPLEMENTATION OF THE H SHARE FULL CIRCULATION BY THE COMPANY
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from Vigonvita Life Sciences Co., Ltd. regarding the 'Proposed Implementation of the H Share Full Circulation'. It details a corporate action involving the conversion of unlisted shares into H shares, which directly impacts the company's capital structure and share listing status. This falls under the category of capital changes and share issuance/conversion procedures. Given the specific nature of 'H Share Full Circulation' announcements in the Hong Kong market, it is best classified as a share/capital change announcement.
2025-11-27 English
ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS
Share Issue/Capital Change Classification · 85% confidence The document is a formal announcement of the final offer price and allotment results for a Global Offering (IPO) of H shares by Vigonvita Life Sciences Co., Ltd. It details the number of Offer Shares, final pricing, subscription levels, Hong Kong Public Offering and International Offering results, and lock-up undertakings—all of which relate to a new share issuance and capital change. This fits the “Share Issue/Capital Change” category (SHA).
2025-11-05 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 89% confidence The document is a corporate announcement listing the company’s board members and committee roles. It is not a full report or earnings release, nor a notification of vote results or proxy materials. This falls under announcements of board/management information (changes or details of the board of directors).
2025-11-05 English
Terms of Reference of the Nomination Committee of the Board of Directors
Governance Information Classification · 91% confidence The document is the Terms of Reference for the Board’s Nomination Committee, detailing internal governance structure, committee composition, duties, authorities, and procedures. It does not announce specific board changes or financial results, but rather sets out internal governance rules. Thus, it fits the Governance Information category (CGR).
2025-11-05 English
Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors
Governance Information Classification · 90% confidence The document is the Terms of Reference (committee charter) of the Board’s Remuneration and Appraisal Committee, laying out its composition, duties, authorities, and procedures. It does not present financial results, regulatory filings, or actual compensation amounts, but rather the internal governance rules and board committee structure. Therefore, it fits the Governance Information (CGR) category.
2025-11-05 English
Terms of Reference of the Audit Committee of the Board of Directors
Governance Information Classification · 90% confidence The document is titled “Terms of Reference of the Audit Committee of the Board of Directors” and outlines the committee’s composition, duties, authorities, procedures, and governance provisions. It is not a financial report, earnings release, or meeting transcript but a governance charter detailing internal rules and board committee structure. This matches the Governance Information category (CGR).
2025-11-05 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.